EIM
PBYI icon

Essex Investment Management’s Puma Biotechnology PBYI Stock Holding History

Essex Investment Management’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-96,000
Closed -$1.03M – 505
2019
Q3 		$1.03M Buy
+96,000
New +$1.04M 0.15% 202
2015
Q3 		– Sell
-3,206
Closed -$374K – 331
2015
Q2 		$374K Sell
3,206
-235
-7% -$42.6K 0.06% 257
2015
Q1 		$812K Buy
3,441
+1,105
+47% +$236K 0.11% 186
2014
Q4 		$442K Hold
2,336
– – 0.06% 241
2014
Q3 		$557K Sell
2,336
-2,434
-51% -$500K 0.09% 214
2014
Q2 		$315K Buy
4,770
+311
+7% +$22.1K 0.05% 298
2014
Q1 		$464K Sell
4,459
-32,908
-88% -$3.87M 0.07% 250
2013
Q4 		$3.87M Buy
37,367
+31,510
+538% +$1.85M 0.55% 46
2013
Q3 		$314K Buy
5,857
+261
+5% +$14.1K 0.05% 302
2013
Q2 		$248K Buy
+5,596
New +$197K 0.04% 298

Other funds holding PBYI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Essex Investment Management's PBYI Position: Q4 2019 in Review

Essex Investment Management sold out of Puma Biotechnology (PBYI) in Q4 2019, closing a stake of 96,000 shares — an estimated $1.03M sold.

Essex Investment Management first reported a position in PBYI in Q2 2013 and held it in 10 quarters. The position peaked at $3.87M in Q4 2013. 133 funds tracked by Wall St. Rank hold PBYI as of Q4 2019.

  • Essex Investment Management reported no remaining Puma Biotechnology position as of Q4 2019 after selling out during the quarter.
  • Essex Investment Management sold 96,000 Puma Biotechnology shares in Q4 2019, an estimated $1.03M.
  • Essex Investment Management first reported a position in Puma Biotechnology in Q2 2013 and held it in 10 quarters.
  • Essex Investment Management's Puma Biotechnology position peaked at $3.87M in Q4 2013.
  • 133 funds tracked by Wall St. Rank held Puma Biotechnology as of Q4 2019.

Based on Essex Investment Management's 13F filing for Q4 2019, filed 10 Feb 2020.